Company Quick10K Filing
MedAmerica Properties
10-K 2019-12-31 Filed 2020-12-22
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-12
10-Q 2019-03-31 Filed 2019-05-14
10-K 2018-12-31 Filed 2019-04-11
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-03
10-Q 2018-03-31 Filed 2018-05-14
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-22
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-05
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-03-25
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-15
10-K 2013-12-31 Filed 2014-03-27
10-Q 2013-09-30 Filed 2013-11-13
10-Q 2013-06-30 Filed 2013-08-02
10-Q 2013-03-31 Filed 2013-08-01
10-K 2012-12-31 Filed 2013-03-25
10-Q 2012-09-30 Filed 2012-11-19
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-28
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-04-04
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-24
10-K 2009-12-31 Filed 2010-04-15
8-K 2020-07-02
8-K 2020-06-16
8-K 2020-05-12
8-K 2020-01-16
8-K 2020-01-10
8-K 2019-12-31
8-K 2019-12-27
8-K 2019-11-27
8-K 2019-05-28
8-K 2019-05-16
8-K 2019-01-30
8-K 2018-11-27
8-K 2018-09-13
8-K 2018-05-23

MedAmerica Properties Financials

MAMP Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 40,869 77% -17.5 -11% 226,103 289,374 72,620 55,706 -24,956 -13,928 243,484
Clovis Oncology (CLVS) 219,222 0% -0.0 -56% 716,892 804,387 134,050 0 -400,184 -394,255 17,741
Cementos Pacasmayo Saa (CPAC) 4,145,433 0% 2,863,245 1,411,882 0 0 0 0 4,145,433
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 122,881 1.0 0% 961,684 868,577 0 0 3,422 14,772 14,360
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash13631481906824827256402516491458327181616006731,3241,15270847935826214076532
Accounts Receivable4504488231,0566363190000
Inventory3074840
PP&E2,8752,6503,3023,2662,9682,7332100232323232323232323
Assets11,14811,40012,97013,53810,1713,1422216483813176402516491466336191721631426951,3381,2007685314313281921183359
Accounts Payable9843058778534293132426775506267
Long-Term Debt2,8482,4872,8804,2524,2583,898
Liabilities6,5176,6128,2318,8776,7436,838564-7594316015988556843092602802883093293756698974501802341279986116153199259295
Stockholders' Equity4,6314,7884,7394,6613,428-2,851-542775-383-563-584-837-6789325621117927-138-303-505-7552441,15996664243234521239-81-226-235
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue1,0561,3146799742,7781,487
Cost of Revenue9408153097653,3042,831
Gross Profit116499370463-527-1,344
R&D
SG&A421375458401506393176103111-896-116127606,702133158675139169138338214110114261330
Tax3079491100000000000000000600000
Net Income-38847-170-160-1,624-6,7481,6423,156-111-279-170-220-68-10,630-133-158-675-139-169-138-341-223-5219-263-331-209-87-134-120-145-9
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-101-314-593-357-341-290-34-394-75-960-128-178-164-116-145-146-276-243139-91-315-217-109-87-51-5936
Cash Investing372-636-183-128-770000-135000
Cash Financing-9364478746542429280372501000525292139841402751845337427-12-12-8-12-12-8